BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

48 related articles for article (PubMed ID: 23506416)

  • 1. Sustained virological response following chronic hepatitis C treatment is associated with improvement in insulin resistance.
    Chan CH; Hansen RD; Gilliver RS; Jones BE
    Intern Med J; 2013 Jun; 43(6):656-62. PubMed ID: 23506416
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adipokines and insulin resistance, predictors of response to therapy in Egyptian patients with chronic hepatitis C virus genotype 4.
    Saad Y; Ahmed A; Saleh DA; Doss W
    Eur J Gastroenterol Hepatol; 2013 Aug; 25(8):920-5. PubMed ID: 23442415
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Time course of insulin resistance during antiviral therapy in non-diabetic, non-cirrhotic patients with genotype 1 HCV infection.
    Petta S; Cammà C; Di Marco V; Cabibi D; Ciminnisi S; Caldarella R; Licata A; Massenti MF; Marchesini G; Craxì A
    Antivir Ther; 2009; 14(5):631-9. PubMed ID: 19704165
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of insulin resistance on sustained response in HCV patients treated with pegylated interferon and ribavirin: a meta-analysis.
    Deltenre P; Louvet A; Lemoine M; Mourad A; Fartoux L; Moreno C; Henrion J; Mathurin P; Serfaty L
    J Hepatol; 2011 Dec; 55(6):1187-94. PubMed ID: 21703195
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insulin resistance and response to therapy in patients infected with chronic hepatitis C virus genotypes 2 and 3.
    Poustchi H; Negro F; Hui J; Cua IH; Brandt LR; Kench JG; George J
    J Hepatol; 2008 Jan; 48(1):28-34. PubMed ID: 17977612
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Homeostasis model assessment of insulin resistance does not seem to predict response to telaprevir in chronic hepatitis C in the REALIZE trial.
    Younossi Z; Negro F; Serfaty L; Pol S; Diago M; Zeuzem S; Andreone P; Lawitz EJ; Roberts S; Focaccia R; Foster GR; Horban A; Lonjon-Domanec I; Coate B; DeMasi R; Picchio G; Witek J
    Hepatology; 2013 Dec; 58(6):1897-906. PubMed ID: 24382638
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interferon-γ-inducible protein-10 in chronic hepatitis C: Correlations with insulin resistance, histological features & sustained virological response.
    Crisan D; Grigorescu MD; Radu C; Suciu A; Grigorescu M
    Indian J Med Res; 2017 Apr; 145(4):543-550. PubMed ID: 28862188
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sustained viral response to interferon and ribavirin in liver transplant recipients with recurrent hepatitis C.
    Abdelmalek MF; Firpi RJ; Soldevila-Pico C; Reed AI; Hemming AW; Liu C; Crawford JM; Davis GL; Nelson DR
    Liver Transpl; 2004 Feb; 10(2):199-207. PubMed ID: 14762857
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New proposal for response-guided peg-interferon-plus-ribavirin combination therapy for chronic hepatitis C virus genotype 2 infection.
    Abe H; Aida Y; Ishiguro H; Yoshizawa K; Seki N; Miyazaki T; Itagaki M; Sutoh S; Ika M; Kato K; Shimada N; Tsubota A; Aizawa Y
    J Med Virol; 2013 Sep; 85(9):1523-33. PubMed ID: 23775277
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recurrent hepatitis C after liver transplantation: a nonrandomized trial of interferon alfa alone versus interferon alfa and ribavirin.
    Ahmad J; Dodson SF; Demetris AJ; Fung JJ; Shakil AO
    Liver Transpl; 2001 Oct; 7(10):863-9. PubMed ID: 11679984
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combined therapy with interferon and low-dose ribavirin in posttransplantation recurrent hepatitis C: a pragmatic study.
    Alberti AB; Belli LS; Airoldi A; de Carlis L; Rondinara G; Minola E; Vangeli M; Cernuschi A; D'Amico M; Forti D; Pinzello G
    Liver Transpl; 2001 Oct; 7(10):870-6. PubMed ID: 11679985
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The evolving relationship between adiponectin and insulin sensitivity in hepatitis C patients during viral clearance.
    Chang ML; Kuo CJ; Pao LH; Hsu CM; Chiu CT
    Virulence; 2017 Oct; 8(7):1255-1264. PubMed ID: 28267407
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The association of hepatitis c virus infection status with serum glucose levels.
    Li Y; Wang X; Yu G; Sun H; Lv J; Chi X; Wu R; Gao X; Niu J
    BMC Gastroenterol; 2019 Jun; 19(1):86. PubMed ID: 31195990
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Insulin Resistance Predicts Virological Response to Interferon-α in Chronic Hepatitis B Patients.
    Wang X; Zhao YR; Liu HL; Ma XH; Zhang Y; Yi RT
    J Clin Gastroenterol; 2016 Jul; 50(6):506-12. PubMed ID: 26600183
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatitis C virus clearance by direct-acting antiviral treatments and impact on insulin resistance in chronic hepatitis C patients.
    Adinolfi LE; Nevola R; Guerrera B; D'Alterio G; Marrone A; Giordano M; Rinaldi L
    J Gastroenterol Hepatol; 2018 Jul; 33(7):1379-1382. PubMed ID: 29228501
    [TBL] [Abstract][Full Text] [Related]  

  • 16. INSULIN RESISTANCE REDUCTION AFTER SUSTAINED VIROLOGICAL RESPONSE WITH DIRECT ACTING ANTIVIRAL:NOT EVERY POPULATION IMPROVES.
    Andrade VG; Yamashiro FDS; Oliveira CV; Moreira A; Winckler FC; Silva GF
    Arq Gastroenterol; 2018; 55(3):274-278. PubMed ID: 30540091
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CURING HEPATITIS C WITH THE NEW DIRECT ACTING ANTIVIRALS DID NOT IMPROVE INSULIN RESISTANCE AFTER ONE YEAR.
    Strauhs-Nitsch L; Campiolo MF; Morsoletto DBG; Pissaia Junior A; Ivantes CAP
    Arq Gastroenterol; 2020; 57(3):267-271. PubMed ID: 33027477
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatitis C virus eradication with direct-acting antiviral improves insulin resistance.
    Russo FP; Zanetto A; Gambato M; Bortoluzzi I; Al Zoairy R; Franceschet E; De Marchi F; Marzi L; Lynch EN; Floreani A; Farinati F; Schaefer B; Burra P; Zoller H; Mega A
    J Viral Hepat; 2020 Feb; 27(2):188-194. PubMed ID: 31596996
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TNF-alpha and CXCL-10 correlation with insulin resistance in patients with chronic hepatitis C virus infection.
    Sayed-Ahmed L; Kotb N; El-Serogy H; El-Shazly S; Eid M
    Egypt J Immunol; 2010; 17(1):101-11. PubMed ID: 22053613
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HCV treatment with direct acting antivirals improves the insulin sensitivity.
    Alsebaey A; Elhelbawy M; Abdel-Razek W; Hashim M; Elshenawy H; Waked I
    Expert Rev Anti Infect Ther; 2019 Sep; 17(9):749-754. PubMed ID: 31393188
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.